David Berman
Senior Vice President, R&D and Oncology iMED Head
business
Sigma
Ireland
Biography
David Berman is Senior Vice President and Head of the Oncology Innovative Medicines unit (iMED) at MedImmune. As iMED head, he leads the cross-functional teams responsible for the strategy, growth, and advancement of the oncology portfolio. Dr. Berman sit’s on AstraZeneca’s Cancer Enterprise team working closely with his small-molecule, GMD and GPPS colleagues.
Research Interest
medicine
